U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT07463287) titled 'High-Risk Transcriptome Molecular Prediction Study of MASH-Associated Colorectal Polyps' on March 05.
Brief Summary: The goal of this observational study is to learn about the molecular characteristics of colorectal polyps in patients with metabolic dysfunction-associated steatohepatitis (MASH) compared to individuals without fatty liver, and to identify potential transcriptomic biomarkers for high-risk polyps. The main questions it aims to answer are: What are the key gene expression differences in adenomatous polyps between MASH patients and non-fatty liver individuals? Can specific high-risk transcriptional molecules in plasma a...